Related Experiment Videos
[Multimodality therapy for diffuse malignant pleural mesothelioma]
Kenichi Tomiyama1, H Ishida, M Miyake
1Department of Chest Surgery, Kitano Hospital, the Tatsuke Kofukai Medical Research Institute, Osaka, Japan.
Kyobu Geka. the Japanese Journal of Thoracic Surgery
|October 30, 2004
Summary
This case study shows successful treatment of malignant pleural mesothelioma (MPM) using extrapleural pneumonectomy and chemotherapy. The patient achieved a 2-year disease-free survival, highlighting a promising multimodal approach for MPM.
Area of Science:
- Oncology
- Thoracic Surgery
- Pulmonology
Background:
- Malignant pleural mesothelioma (MPM) has a poor prognosis and lacks a standard treatment.
- Multimodality therapy, including extrapleural pneumonectomy and perioperative chemotherapy/radiotherapy, shows potential for long-term survival in selected patients.
Observation:
- A patient presented with diffuse malignant pleural mesothelioma, a large malignant pleural effusion, and pneumothorax.
- Diagnosis of epithelial type MPM was confirmed via thoracoscopic surgery.
Findings:
- The patient underwent extrapleural pneumonectomy, with surgical findings revealing chest wall invasion and positive mediastinal lymph nodes.
- Postoperative chemotherapy with cisplatin and gemcitabine was administered.
- The patient achieved 2-year disease-free survival.
Implications:
- This case demonstrates the successful application of a multimodal treatment strategy for advanced MPM.
- Combination therapy, including surgery and chemotherapy, can lead to favorable outcomes in select MPM patients.
- Further research into optimizing multimodal treatments for MPM is warranted.